Our client’s specialty rare-disease medication needed to be reconstituted by patients at home.
Even after training by their HCP, many patients were finding this to be a complicated process, struggling to engage with the product, and requiring supplemental education.
The client was looking for a more robust approach to training that would significantly improve their patients’ experience.
Working with the client, we reviewed the pain points of the existing process and identified what mattered most to the patients during the treatment schedule.
We then presented the best options for a low-volume, high-impact education program, and quickly built a dedicated team of on-demand clinical educators (ODCE) with experience in reconstitution training.
Finally, we offered in-person and virtual training based on patient preference, along with follow-up support as required.
We seamlessly transitioned the training program from the previous partner to Inizio Engage within 3 months of the client’s initial request, making new, more appropriate training accessible to all patients.
Within the first three months post-transition, patient enrollment increased 63% versus the forecast, with requests for live training up from 4% to 25%.
We were able to rapidly increase ODCE resources to effectively meet the increased demand and better support the client’s patient education needs.
